
Starclop 75mg Tablet
Marketer
Zinnia Life Sciences
Salt Composition
Clopidogrel (75mg)
Overview Starclop 75mg Tablet
CardioGuard 75mg tablets are antiplatelet agents, effectively reducing blood clot formation within the circulatory system. This significantly lowers the risk of stroke or myocardial infarction. A prevalent cardiac prophylactic, CardioGuard 75mg is prescribed for individuals at elevated risk of cardiovascular events. This includes patients with peripheral artery disease (vascular compromise due to arterial narrowing), recent stroke or heart attack, arrhythmias, and those who have undergone coronary interventions like stent placement. It's also used adjunctively with other medications to manage myocardial infarction and unstable angina. Administer this medication at the same time daily, regardless of food intake. Consistent use is crucial; discontinuation increases the risk of cardiac events. The most frequent adverse effect is increased bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While usually mild and self-limiting, persistent or concerning bleeding requires immediate medical attention. This medication is contraindicated in patients with active internal bleeding, such as from a gastric ulcer or intracranial hemorrhage. Prior to initiating therapy, disclose any history of bleeding disorders or recent major trauma/surgery to your physician. Temporary cessation may be necessary before scheduled procedures.
Uses of Starclop 75mg Tablet
Avoiding cardiac arrest and cerebrovascular accidents
Major Benefits of Starclop 75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Starclop 75mg Tablets can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Starclop 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Starclop 75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Starclop 75mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Starclop 75mg Tablet works:
Platelet aggregation inhibitor Starclop 75mg tablets reduce the risk of cardiovascular events. Their mechanism of action involves inhibiting platelet adhesion, thus hindering clot formation and subsequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Starclop 75mg Tablet and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Starclop 75mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Starclop 75mg tablets appear compatible. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Starclop 75mg Tablets.
KidneySAFE IF PRESCRIBED
Starclop 75mg tablets can be administered to patients with renal impairment without requiring a change in dosage.
LiverSAFE IF PRESCRIBED
Starclop 75mg tablets can be administered to patients with hepatic impairment without the need for dosage modification.
What if you forget to take Starclop 75mg Tablet :
Should you forget a Starclop 75mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Starclop 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
